A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
ImCheck ticks $21.8m series A box
Boehringer Ingelheim Venture Fund has co-led a $21.8m round for ImCheck Therapeutics, established with the support of Satt Sud-Est.
NuNano probes $515,000 investment
The Bristol spinout has secured capital from investors including the university’s Enterprise Fund.
UBC has Commonsense for licence
British Columbia University has signed a licensing agreement with Commonsense for a treatment of asthma and other allergic conditions.
Vivet Therapeutics digests $41m series A
Exploiting research conducted at Navarra University and Harvard Medical School, Vivet Therapeutics is working on gene therapies for metabolic diseases.
Sosei Group sends $45m Mina’s way
Sosei will pay $45m for a 25% stake in RNA therapy developer Mina Therapeutics and could buy the NTNU spinout outright for about $180m more.
Z Factor calculates $9m series A
Cambridge Enterprise and Cambridge Innovation Capital both participated in the funding round, which is based on research at the Cambridge Institute for Medical Research.
Virolock seals $75,000 funding
Virolock Technologies was spun out of Penn State to commercialise a portable device that boosts early detection of viral infections.
Congenica convinces more investors for series B
Future Planet Capital was among the investors that added an undisclosed sum to the $10m in series B funding Congenica raised in February.
Ultrahaptics contacts investors for series B
IP Group has returned for the haptics technology developer’s $23m series B round, two years after backing a series A round.
TEC Edmonton stars in Tsinghua deal
TEC Edmonton has inked an agreement with Tsinghua University’s incubator TusStar that will enable both partners to better support their portfolio companies.
The Paris-Saclay Seed Fund has participated in a funding round for Damae Medical, which has developed technology to detect skin cancer without the need for biopsies.
Evidation veers to Sanofi in $10m round
Evidation Health, a healthcare data platform co-developed by Stanford, took its total funding to $31m in a round led by Sanofi-Genzyme BioVentures that included GE Ventures.
Swinburne and Stuttgart to collaborate on spinouts
The two universities have signed a partnership agreement that aims to increase research collaboration, boost commercialisation activities and develop a joint PhD program.
Saarland pulls in team to spin out research
The university has spun out Mac Panther Materials, its first spinout using an external team of co-founders.
